The UniPR1331 ability to reduce the PC3 stem marker CD44 gave us the rationale to investigate the association with CPT and DTX, due to the critical role played by prostate cancer stem cells in chemoresistance [30]. This evidence concerns the gene CD44 and prostate cancer.